Doctorglasses Chain Co

Doctorglasses Chain Co R&D Expenses

The Research & Development Expenses of Doctorglasses Chain Co (300622.SZ) as of Nov 11, 2026 is 2.01 M CNY. In the previous year, Research & Development Expenses was 3.08 M CNY — a change of -34.59% (lower).

R&D Expenses

2.01 MCNY

YoY

-34.59%

Last updated:

Research & Development Expenses of Doctorglasses Chain Co is 2025 2.01 M CNY. Research & Development Expenses of Doctorglasses Chain Co was 2024 3.08 M CNY. It decreases by -34.59% lower compared to the previous year.

The Doctorglasses Chain Co R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2023
4.67 M CNY
Jan 1, 2024
3.08 M CNY
Jan 1, 2025
2.01 M CNY
The Doctorglasses Chain Co R&D Expenses history
YEARR&D ExpensesYoY
2.01 MCNY-34.59%
3.08 MCNY-34.04%
4.67 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Doctorglasses Chain Co Stock analysis

What does Doctorglasses Chain Co do? Doctorglasses Chain Co., Ltd. generates revenue through its chain of optical retail stores offering frames, lenses, sunglasses, reading glasses, contact lenses, and care solutions, alongside optometry and optics services. The company operates under the brands President optical, Doctor’s Glasses, zele, and Tong, selling products via direct stores, e-commerce, and wholesale channels. Its primary customer segments include individuals seeking eyewear solutions and optometry services, with a focus on retail and online sales channels. The firm’s product portfolio spans prescription and non-prescription eyewear, including specialized options like reading glasses and contact lenses, supported by care solutions for lens maintenance. Brands such as President optical and Doctor’s Glasses target diverse consumer segments, while zele and Tong cater to specific market niches. Sales through direct stores and e-commerce platforms drive the majority of revenue, complemented by wholesale distribution to other retailers. Doctorglasses Chain Co., Ltd. serves both individual consumers and business clients through its retail and wholesale models. The company’s revenue streams are derived from the sale of eyewear products and associated services, with a strong emphasis on brand-specific product lines. Direct store sales and e-commerce represent the most significant distribution channels, ensuring broad market coverage across its operational regions. Doctorglasses Chain Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Doctorglasses Chain Co stock

Research & Development Expenses of Doctorglasses Chain Co is 2.01 M CNY in 2025.

Research & Development Expenses of Doctorglasses Chain Co changed from 3.08 M CNY to 2.01 M CNY, representing a -34.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Doctorglasses Chain Co since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Doctorglasses Chain Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Doctorglasses Chain Co

All Key Metrics — Doctorglasses Chain Co